More than 100 million COVID vaccines were rejected in December, says a UNICEF official, while 681 million shipments are not used in nearly 90 countries.
Poor countries last month rejected more than 100 million COVID-19 vaccines released by the global COVAX program, mainly due to near-term losses, said a UNICEF official.
This figure shows the difficulty in vaccinating people around the world despite the increasing number of jabs, COVAX is approaching to deliver one billion doses to approximately 150 countries.
“More than 100 million people were turned away in December alone,” Etleva Kadilli, UNICEF’s regional director, told lawmakers at the European Parliament on Thursday.
The main reason for the refusal was the provision of a long-term dose, he said.
Poor countries are also being forced to delay delays because they do not have enough storage facilities, said Kadilli, including the lack of refrigerators for vaccinations.
UNICEF has not immediately responded to the question of the amount of dosage rejected so far.
In addition to the rejected standards, many others are not used in warehouses in developing countries.
UNICEF’s data on food and vaccine use shows that 681 million shipments here are not being used in some 90 poor countries around the world, according to CARE, a charitable organization, which released the data on human resources.
More than 30 poor countries, including major countries such as the Democratic Republic of the Congo and Nigeria, have used less than half of what they have received, CARE said, citing UNICEF in detail.
COVAX, a global program run by the World Health Organization, has provided a vaccine for COVID-19 989 million to 144 countries, according to a GAVI study, the vaccine coordinator, which oversees the program.
COVAX is a major supplier to many poor countries but it is not the only one. Some countries purchase their own dosage or use alternative vaccines.
Contributions to poor countries have been severely limited due to the lack of vaccinations, as rich countries have achieved the highest levels since December 2020.
But in the past quarter, shipments have increased dramatically as a result of donations from rich countries that have vaccinated large numbers of people.
By January, 67 percent of the people in rich countries had received adequate vaccination, while only 8 percent of poor countries had received their first dose, WHO figures show.
Consumer pressure gripped many receiving countries unprepared.
“We have countries pushing the current level for the second quarter of 2022,” Kadilli said.
Of the 15 million units from the EU rejected, three-quarters were AstraZeneca shooters with a shelf less than 10 weeks after arrival, according to a UNICEF image shown to EU lawmakers.
Wealthy countries offering long-term vaccines have become a “major problem” for COVAX, a WHO official said last month, as large doses were lost.
As many as one million vaccines expired in Nigeria in November without use.